Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 19-01 

Phase III randomised double blind study of Letrozole versus placebo in women with primary breast cancer completing five or more years of adjuvant Tamoxifen

DESIGN

Design Trial 19-01

Results & Publications


Publications

Study Chair
Prof. Monica Castiglione - Bern, Switzerland

Trial Coordinator
Rita Pfister
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 389 93 91
Fax: +41 31 389 92 73
Email: rita.pfister@ibcsg.org

Date of Activation
September 3, 2001

Date of Closure
May 31, 2002

Targeted Accrual
4800 patients

Final Accrual
5031 patients


Results Publications Results & Publications


News

24.10.2014:
A few impressions from our audits

13.10.2014:
The next IBCSG Annual Meeting will take place in Vienna, Austria on March 21st and 22nd, 2015 in

13.10.2014:
Breast Cancer Conference BCC 2015 18 - 21 March 2015 / Vienna / Austria  

All News

 
  Print